Date Filed | Type | Description |
03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/04/2020 |
4
| BANSAL AJAY (PFO;CFO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns:
| Granted 63,659 shares
@ $0 |
|
11/05/2019 |
4
| BANSAL AJAY (PFO;CFO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns:
| Granted 75,000 shares
@ $0 Granted 140,000 options to buy
@ $9.66, valued at
$1.4M
|
|
11/05/2019 |
3
| BANSAL AJAY (PFO;CFO/Urovant Sciences, Inc.) has filed a Form 3 on Urovant Sciences Ltd. |
07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/05/2019 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on ViewRay, Inc.
Txns:
| Granted 20,661 shares
@ $0 Granted 36,038 options to buy
@ $8.47, valued at
$305.2k
|
|
04/18/2018 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on ViewRay, Inc.
Txns:
| Granted 110,000 options to buy
@ $7.09, valued at
$779.9k
|
|
02/23/2017 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on ViewRay, Inc. |
01/25/2017 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on ViewRay, Inc. |
01/20/2017 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on ViewRay, Inc. |
12/19/2016 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on ViewRay, Inc. |
09/15/2016 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on ViewRay, Inc. |
06/16/2016 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on ViewRay, Inc.
Txns:
| Granted 550,000 options to buy
@ $4.6, valued at
$2.5M
|
|
06/16/2016 |
3
| BANSAL AJAY (CFO) has filed a Form 3 on ViewRay, Inc. |
01/28/2016 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Granted 69,984 options to buy
@ $0.65, valued at
$45.5k
|
|
10/01/2015 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Granted 32,500 options to buy
@ $1.48, valued at
$48.1k
|
|
04/20/2015 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Granted 32,500 options to buy
@ $2.32, valued at
$75.4k
|
|
12/22/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/24/2013 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Granted 65,000 options to buy
@ $13.48, valued at
$876.2k
|
|
08/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/29/2013 |
4
| BANSAL AJAY (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns:
| Granted 5,000 options to buy
@ $15, valued at
$75k
Granted 40,000 options to buy
@ $15, valued at
$600k
|
|
03/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/13/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/10/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
06/02/2009 |
4
| BANSAL AJAY (EVP Corp Dev and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE |
06/02/2009 |
3
| BANSAL AJAY (EVP Corp Dev and CFO) has filed a Form 3 on LEXICON PHARMACEUTICALS, INC./DE |